115250-39-0 Usage
Description
Tetrabenzyl-voglibose is a chemical derivative of Voglibose, an α-Glucosidase inhibitor. It is a compound that has been modified with four benzyl groups, which may enhance its properties or applications in various fields. The compound is known for its potential role in the management of diabetes and other related conditions.
Uses
Used in Pharmaceutical Industry:
Tetrabenzyl-voglibose is used as an antidiabetic agent for the treatment of diabetes mellitus. As a derivative of Voglibose, it functions as an α-Glucosidase inhibitor, which helps in slowing down the digestion of carbohydrates and reducing the spike in blood sugar levels after a meal. This makes it a valuable component in the development of medications for diabetes management.
Used in Research and Development:
In the field of research and development, Tetrabenzyl-voglibose may be utilized as a starting material or intermediate for the synthesis of other bioactive compounds. Its unique structure and properties can be explored for potential applications in drug discovery, particularly in the areas of metabolic disorders and related conditions.
Used in Drug Delivery Systems:
Similar to Gallotannin, Tetrabenzyl-voglibose could potentially be incorporated into novel drug delivery systems to enhance its bioavailability, delivery, and therapeutic outcomes. This may involve the use of various organic and metallic nanoparticles as carriers for the compound, aiming to improve its overall effectiveness in treating diabetes and other conditions.
Please note that the provided materials only mention the use of Tetrabenzyl-voglibose as an antidiabetic. The other potential uses mentioned above are speculative and based on the general properties and applications of similar compounds. Further research and development would be required to confirm these potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 115250-39-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,2,5 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 115250-39:
(8*1)+(7*1)+(6*5)+(5*2)+(4*5)+(3*0)+(2*3)+(1*9)=90
90 % 10 = 0
So 115250-39-0 is a valid CAS Registry Number.
InChI:InChI=1/C38H45NO7/c40-22-33(23-41)39-34-21-38(42,28-43-24-29-13-5-1-6-14-29)37(46-27-32-19-11-4-12-20-32)36(45-26-31-17-9-3-10-18-31)35(34)44-25-30-15-7-2-8-16-30/h1-20,33-37,39-42H,21-28H2/t34?,35-,36?,37-,38-/m0/s1
115250-39-0Relevant articles and documents
Synthesis method of voglibose
-
Paragraph 0060; 0061; 0093-0095, (2021/08/07)
The invention provides a synthesis method of voglibose, and solves the technical problems that in an existing synthesis method of voglibose, raw materials are difficult to obtain, high in price, large in investment, low in yield and not suitable for industrial production. The synthesis method comprises the steps: synthesizing a compound V by taking glucose monohydrate and sodium acetate as raw materials through eleven reaction steps; and preparing a compound VIII from the compound V through an addition reaction, a ring-opening reaction and an aldol condensation reaction, and thus obtaining voglibose through amination reduction of the compound VIII. The synthesis method of voglibose can be widely applied to the technical field of voglibose synthesis methods.
Synthesis of valiolamine and its N-substituted derivatives AO-128, validoxylamine G, and validamycin G via branched-chain inosose derivatives
Fukase,Horii
, p. 3651 - 3658 (2007/10/02)
-
